We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current SGRY market cap is 3.12B. The company's latest EPS is USD -0.0940 and P/E is -261.91.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 616.1M | 753.6M | 667.3M | 667.6M | 674.1M |
| Operating Income | 74.6M | 150.4M | 60.2M | 89.1M | 90.8M |
| Net Income | -25M | -23.4M | -24.9M | 18.9M | -4.9M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 1.83B | 1.91B | 2.28B | 2.59B | 2.75B |
| Operating Income | 219.9M | 188.7M | 304.4M | 371.2M | 357.9M |
| Net Income | -110.5M | -155.6M | -81.2M | -54.6M | -11.9M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 6.54B | 6.68B | 6.64B | 6.62B | 6.78B |
| Total Liabilities | 4.09B | 3.4B | 3.36B | 3.31B | 3.46B |
| Total Equity | 2.11B | 2.94B | 2.94B | 2.98B | 2.99B |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 5.02B | 5.41B | 6.12B | 6.68B | 6.88B |
| Total Liabilities | 3.32B | 3.79B | 3.82B | 3.4B | 3.51B |
| Total Equity | 983.4M | 882.1M | 1.97B | 2.94B | 3.03B |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 151.6M | 158.8M | 74.5M | 126.6M | 231.2M |
| Investing | -235.7M | -307.9M | -70.7M | -141.9M | -167.5M |
| Financing | -151M | 42.1M | -41.2M | -90.2M | -110.6M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 129.5M | 246.9M | 87.1M | 158.8M | 293.8M |
| Investing | -85.2M | -88.4M | -331.7M | -307.9M | -225.6M |
| Financing | -135.9M | 66.7M | 316.3M | 42.1M | -155.2M |
| Market Cap | 3.12B |
| Price to Earnings Ratio | -261.91 |
| Price to Sales Ratio | 1.13 |
| Price to Cash Ratio | 15.91 |
| Price to Book Ratio | 0.93 |
| Dividend Yield | - |
| Shares Outstanding | 126.61M |
| Average Volume (1 week) | 743.8k |
| Average Volume (1 Month) | 783.37k |
| 52 Week Change | -37.94% |
| 52 Week High | 45.79 |
| 52 Week Low | 22.05 |
| Spread (Intraday) | 1.11 (4.39%) |
| Company Name | Surgery Partners Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.surgerypartners.com |
| Industry | gen med & surgical hospitals (8062) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
